Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: a comprehensive review

FS Bersani, A Minichino, PG Enticott… - European …, 2013 - cambridge.org
Deep transcranial magnetic stimulation (TMS) is a technique of neuromodulation and
neurostimulation based on the principle of electromagnetic induction of an electric field in …

Smoking behaviour and mental health disorders—mutual influences and implications for therapy

A Minichino, FS Bersani, WK Calò, F Spagnoli… - International Journal of …, 2013 - mdpi.com
Tobacco use is strongly associated with a variety of psychiatric disorders. Smokers are more
likely than non-smokers to meet current criteria for mental health conditions, such as mood …

Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine

Y Tsuda, J Saruwatari, N Yasui-Furukori - BMJ open, 2014 - bmjopen.bmj.com
Objective To clarify the effects of smoking on the disposition of two commonly used
antipsychotics, olanzapine and clozapine, and to create standards to adjust the doses of …

Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition

G Schoretsanitis, AEA Yağcıoğlu, CJ Ruan… - Schizophrenia …, 2023 - Elsevier
During weak induction (from smoking and/or valproate co-prescription), clozapine ultrarapid
metabolizers (UMs) need very high daily doses to reach the minimum therapeutic …

Association between clozapine plasma concentrations and treatment response: a systematic review, meta-analysis and individual participant data meta-analysis

F Tralongo, C Konecki, C Feliu, A Kaladjian… - Clinical …, 2023 - Springer
Abstract Background and Objectives Although therapeutic drug monitoring of clozapine is
recommended, its optimisation is often adjusted only on the basis of dosage. The aim of this …

Is there a future for CYP1A2 pharmacogenetics in the optimal dosing of clozapine?

CJ Ruan, J de Leon - Pharmacogenomics, 2020 - Taylor & Francis
In 1989, clozapine (CLO) was marketed in the USA with limited pharmacokinetic studies. In
1994, Bertilsson et al. described CYP1A2 as explaining 70% of CLO metabolism [1]. While …

[HTML][HTML] The role of cerebellum in unipolar and bipolar depression: a review of the main neurobiological findings

A Minichino, FS Bersani, G Trabucchi… - Rivista di …, 2014 - rivistadipsichiatria.it
Evidences from studies on patients with overt cerebellar diseases as well as on healthy
individuals suggest a possible role for the cerebellum in cognition, mood and behaviour …

Pharmacogenomic variants and drug interactions identified through the genetic analysis of clozapine metabolism

AF Pardiñas, M Nalmpanti… - American Journal of …, 2019 - Am Psychiatric Assoc
Objective: Clozapine is the only effective medication for treatment-resistant schizophrenia,
but its worldwide use is still limited because of its complex titration protocols. While the …

[PDF][PDF] Cingulate Cortex in Schizophrenia: its relation with negative symptoms and psychotic onset. A review study

FS Bersani, A Minichino, M Fojanesi… - Eur Rev Med …, 2014 - academia.edu
OBJECTIVE: The cingulate cortex is a functionally heterogeneous region involved in diverse
cognitive and emotional processes. It is a region of special interest to investigate the …

Olanzapine as the ideal “trip terminator”? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance …

G Valeriani, O Corazza, FS Bersani… - Human …, 2015 - Wiley Online Library
Objective The pharmacological self‐management of novel psychoactive substance (NPS)‐
induced psychopathological consequences represents a fast growing phenomenon. This is …